Abstract:Perospirone is a novel atypical antipsychotic with a unique combination of 5-HT1A receptor agonism as well as 5-HT2A and D2 receptor antagonism. A simple rapid and selective LC–MS method utilizing a single quadrupole mass spectrometer was developed and validated for the determination of perospirone hydrochloride in human plasma. N-hexane was used to extract perospirone hydrochloride and amlodipine benzenesulfonate (internal standard (IS)) from an alkaline plasma sample. LC separation was performed on a XTerra ® MS C18 column (100mm×2.1mm, i.d. 3.5μm) using methanol −10mM ammonium acetate (84:16, v/v) as a mobile phase. The quantification of target compounds was obtained by using a selected ion monitoring (SIM) at m/z 427.5 [M+H]+ for perospirone hydrochloride, and at m/z 431.4 [M+Na]+ for IS (amlodipine benzenesulfonate). Perospirone and IS eluted as sharp, symmetrical peaks with retention times of 3.11±0.01min and 4.15±0.2min, respectively. Calibration curves of perospirone hydrochloride in human plasma at concentrations ranging from 0.10 to 21.1ng/mL exhibited excellent linearity (r2=0.9997). The mean absolute recovery of the drug from plasma was more than 85%. Intra- and inter-day relative standard deviations were less than 6.43% and 11.9% for perospirone hydrochloride at the range from 0.32 to 10.6ng/mL. Stability characteristics of the drug-containing plasma were thoroughly evaluated to establish appropriate conditions to process, store and prepare for chromatographic analysis without inducing significant chemical degradation. The following pharmacokinetic parameters were elucidated after administering a single dose of 8mg perospirone hydrochloride. The area under the plasma concentration versus time curve from time 0 to 24h (AUC0–24) was 15.48±4.23μg/Lh; peak plasma concentration (Cmax) was 2.79±0.78μg/L; time to Cmax (Tmax) was 1.79±0.45h; and elimination half-life (t1/2) 6.78±1.38h. The described assay method showed acceptable precision, accuracy, linearity, stability, and specificity and can be used for pharmacokinetic studies, therapeutic drug monitoring, and drug abuse screening.

Estimation of Perospirone in Human Plasma by LC–MS–MS and Its Application to Pharmacokinetics Study

Determination of perospirone by liquid chromatography/electrospray mass spectrometry: application to a pharmacokinetic study in healthy Chinese volunteers.

A novel and robust analytical method for the quantification of perospirone in human plasma using an LC–MS/MS system with self-internal standard calibration

Determination of Perospirone Hydrochloride and Pharmacokinetics in Human Plasma by HPLC-MS

HPLC-MS/MS Determination of Quetiapine in Human Plasma

Determination of Ziprasidone by UPLC-MS-MS and Its Application to a Pharmacokinetic Study of Chinese Schizophrenics

A Sensitive LC–MS/MS Method for Analysis of Pericyazine in Presence of 7-Hydroxypericyazine and Pericyazine Sulphoxide in Human Plasma and Its Application to a Comparative Bioequivalence Study in Chinese Healthy Volunteers

Pharmacokinetics study of levosulpiride in human plasma by HPLC-MS/MS

Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry for the Determination of Atypical Antipsychotics and Some Metabolites in in Vitro Samples.

Development and Validation of a Sensitive and Robust LC–MS/MS with Electrospray Ionization Method for Simultaneous Quantitation of Quetiapine and Its Active Metabolite Norquetiapine in Human Plasma

Simultaneous Determination of Quetiapine and Three Metabolites in Human Plasma by High-Performance Liquid Chromatography-Electrospray Ionization Mass Spectrometry

Liquid chromatography/positive ion electrospray tandem mass spectrometry method for the quantification of hydrochloride meptazinol in human plasma: application to a pharmacokinetic study.

The Validation of an LC-MS Method for the Determination of Risperidone and Its Active Metabolite 9-Hydroxyrisperidone in Human Plasma

Simultaneous Determination of Pirfenidone and Its Metabolite in Human Plasma by Liquid Chromatography–Tandem Mass Spectrometry: Application to a Pharmacokinetic Study

Quantitative Detection of Ambroxol in Human Plasma Using HPLC-APCI-MS/MS: Application to a Pharmacokinetic Study

Lc-Ms-Ms Determination and Pharmacokinetic Study of Clozapine in Human Plasma

A Sensitive LC–ESI–MS–MS Method for the Determination of Huperzine A in Human Plasma: Method and Clinical Applications

Sensitive and Selective LC-MS-MS Assay for the Quantification of Palonosetron in Human Plasma and Its Application to a Pharmacokinetic Study

LC -MS Determination of Propiverine in Human Plasma

Determination of Azelnidipine by Lc-Esi-Ms and Its Application to A Pharmacokinetic Study in Healthy Chinese Volunteers

Determination of Lansoprazole in Human Plasma Using LC-MS and Pharmacokinetic Study in Chinese Healthy Volunteers